Price
$66.3
Decreased by -0.87%
Dollar Volume (20D)
10.69 M
ADR%
2.04
Earnings Report Date (estimate)
May 6, 24
Shares Float
15.04 M
Shares Outstanding
20.98 M
Shares Short
197.03 K
Market Cap.
1.4 B
Beta
0.8
Price / Earnings
78.68
20D Range
65.52 70.81
50D Range
54.62 70.81
200D Range
48.2 70.81
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Feb 29, 24 1
Increased by +31.58%
0.86
Increased by +16.28%
Nov 8, 23 1.27
Increased by +98.44%
0.84
Increased by +51.19%
Aug 9, 23 1.28
Increased by +884.62%
0.68
Increased by +88.24%
May 8, 23 1.17
Increased by +1.07 K%
0.35
Increased by +234.29%
Mar 9, 23 0.76
Increased by +40.74%
0.67
Increased by +13.43%
Nov 9, 22 0.64
Decreased by -36.63%
0.55
Increased by +16.36%
Aug 8, 22 0.13
Decreased by -80.6%
0.22
Decreased by -40.91%
May 10, 22 -0.12
Decreased by -111.54%
0.09
Decreased by -233.33%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 131.83 M
Increased by +57.27%
9.94 M
Increased by +215.58%
Increased by +7.54%
Increased by +173.49%
Jun 30, 23 116.55 M
Increased by +57.81%
6.25 M
Increased by +141.85%
Increased by +5.36%
Increased by +126.52%
Mar 31, 23 106.79 M
Increased by +65.62%
1.44 M
Increased by +107.15%
Increased by +1.35%
Increased by +104.32%
Dec 31, 22 94.23 M
Increased by +54.66%
-4.24 M
Increased by +82.42%
Decreased by -4.5%
Increased by +88.63%
Sep 30, 22 83.82 M
Increased by +61.01%
-8.6 M
Decreased by -93.39%
Decreased by -10.26%
Decreased by -20.11%
Jun 30, 22 73.86 M
Increased by +51.89%
-14.92 M
Decreased by -5.79%
Decreased by -20.21%
Increased by +30.35%
Mar 31, 22 64.48 M
Increased by +18.26%
-20.13 M
Decreased by -23.51 K%
Decreased by -31.22%
Decreased by -19.89 K%
Dec 31, 21 60.93 M
Increased by +6.42%
-24.14 M
Decreased by -563.99%
Decreased by -39.61%
Decreased by -523.92%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.